14355

...abbaxy-Pfizer maybe innocent on the face of it, but does it walk a fine line with the insider trading regulations of SEBI? Expert legal personnel are of the view that there is no real spout ...

5

...o Ranbaxy is seen exceeding $1.5 billion, say sources. This is also one of the biggest settlement in the global pharma industry. The settlement covers key markets in eight countries, including the ...

India's Ranbaxy settled a major patent dispute Wednesday with rival Pfizer over the launch of a generic version of Ranbaxy's key cholesterol...

120

CNBC-TV18 has learnt that Pfizer could be interested in Ranbaxy. There is no confirmation from Pfizer, but sources say that it has informed its bankers to approach institutional shareholders. A bid ...

1125

Pfizer has sued Ranbaxy for a fresh patent infringement in Delaware court, reports CNBC-TV18. The patent infringement relates to Lipitor and Caduet. Pfizer’s move is aimed at delaying Ranbaxy's ...

21015

...Pfizer's application for re-issue of the Lipitor patent, reports CNBC-TV18. The US PTO's decision is in favour of Ranbaxy. The Indian pharma major plans to launch a Lipitor generic version In US ...